ASCO Clinical Practice Guidelines   For more information on these guidelines, including information about planned guidelines, please access the ASCO.org guidelines page. Clinical practice guidelines serve as a guide for doctors and outline appropriate methods of treatment and care. Guidelines can address specific clinical situations (disease-oriented) or use of approved medical products, procedures, or tests (modality-oriented). Using the best available evidence, ASCO expert panels identify and develop practice recommendations for specific areas of cancer care that would benefit from the availability of practice guidelines. Topics for guidelines are selected on the basis of significant clinical or economic importance; presence of variations in patterns of, or access to, care; availability of suitable data; and ethical considerations. ASCO.org guidelines page Assays and Predictive Markers: Breast Cancer: Gastrointestinal Cancer: Genitourinary Cancer: Head and Neck Cancer: Hematologic Malignancies: Thoracic Cancer: Supportive Care and Quality of Life: Survivorship: ASCO Special Articles ASCO Clinical Practice Guidelines Assays and Predictive Markers: American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer Published in JCO, Vol 25, Issue 33 (November 20), 2007: 5287-5312 American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer Published in JCO, Vol. 25, Issue 1 (January 1), 2007: 118-145 ASCO 2006 Update of Recommendations for the Use of Tumor Markers in Gastrointestinal Cancer Published in JCO, Vol. 24, Issue 33 (November 20), 2006: 5313-5327 American Society of Clinical Oncology Technology Assessment: Chemotherapy Sensitivity and Resistance Assays Published in JCO, Vol. 22, Issue 17 (September 1), 2004: 3631-3638 American Society of Clinical Oncology Policy Statement Update: Genetic Testing for Cancer Susceptibility Published in JCO, Vol. 21, Issue 12 (June 15), 2003: 2397-2406 1997 Update of Recommendations for the Use of Tumor Markers in Breast and Colorectal Cancer Published in JCO, Vol. 16, Issue 2 (February), 1998: 793-795 Statement of the American Society of Clinical Oncology: Genetic Testing for Cancer Susceptibility Published in JCO, Vol. 14, Issue 5 (May), 1996: 1730-1736 Clinical Practice Guidelines for the Use of Tumor Markers in Breast and Colorectal Cancer Published in JCO, Vol. 14, Issue 10 (October), 1996: 2843-2877 [top] Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update on the Use of Pharmacologic Interventions Including Tamoxifen, Raloxifene, and Aromatase Inhibition for Breast Cancer Risk Reduction Published in JCO, Vol 27, Issue 19 (July 1), 2009: 3235-3258 American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer Published in JCO, Vol 25, Issue 33 (November 20), 2007: 5287-5312 American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer Published in JCO, Vol. 25, Issue 1 (January 1), 2007: 118-145 American Society of Clinical Oncology 2006 Update of the Breast Cancer Follow-Up and Management Guidelines in the Adjuvant Setting Published in JCO, Vol. 24, Issue 31 (November 1), 2006: 5091-5097 American Society of Clinical Oncology Guideline Recommendations for Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer Published in JCO, Vol. 23, Issue 30 (October 20), 2005: 7703-7720 American Society of Clinical Oncology Technology Assessment on the Use of Aromatase Inhibitors As Adjuvant Therapy for Postmenopausal Women With Hormone Receptor-Positive Breast Cancer: Status Report 2004 Published in JCO, Vol. 23, Issue 3 (January 20), 2005: 619-629 American Society of Clinical Oncology 2003 Update on the Role of Bisphosphonates and Bone Health Issues in Women With Breast Cancer Published in JCO, Vol. 21, Issue 21 (November 1), 2003: 4042-4057 American Society of Clinical Oncology Technology Assessment of Pharmacologic Interventions for Breast Cancer Risk Reduction Including Tamoxifen, Raloxifene, and Aromatase Inhibition Published in JCO, Vol. 20, Issue 15 (August 1), 2002: 3328-3343 American Society of Clinical Oncology Technology Assessment on the Use of Aromatase Inhibitors as Adjuvant Therapy for Women With Hormone Receptor-Positive Breast Cancer: Status Report 2002 Published in JCO, Vol. 20, Issue 15 (August 1), 2002: 3317-3327 2000 Update of Recommendations for the Use of Tumor Markers in Breast and Colorectal Cancer: Clinical Practice Guidelines of the American Society of Clinical Oncology Published in JCO, Vol. 19, Issue 6 (March 15), 2001: 1865-1878 Ethical, Scientific, and Regulatory Perspectives Regarding the Use of Placebos in Cancer Clinical Trials Published in JCO, Vol 26, Issue 8 (March 10), 2008:1371-1378 Postmastectomy Radiotherapy: Clinical Practice Guidelines of the American Society of Clinical Oncology Published in JCO, Vol. 19, Issue 5 (March 1), 2001: 1539-1569 American Society of Clinical Oncology Technology Assessment on Breast Cancer Risk Reduction Strategies: Tamoxifen and Raloxifene Published in JCO, Vol. 17, Issue 6 (June), 1999: 1939-1955 American Society of Clinical Oncology 1998 Update of Recommended Breast Cancer Surveillance Guidelines Published in JCO, Vol. 17, Issue 3 (March), 1999: 1080-1082 1997 Update of Recommendations for the Use of Tumor Markers in Breast and Colorectal Cancer Published in JCO, Vol. 16, Issue 2 (February), 1998: 793-795 Recommended Breast Cancer Surveillance Guidelines Published in JCO, Vol. 15, Issue 5 (May), 1997: 2149-2156 Clinical Practice Guidelines for the Use of Tumor Markers in Breast and Colorectal Cancer Published in JCO, Vol. 14, Issue 10 (October), 1996: 2843-2877 [top] Gastointestinal Cancer: ASCO 2006 Update of Recommendations for the Use of Tumor Markers in Gastrointestinal Cancer Published in JCO, Vol. 24, Issue 33 (November 20), 2006: 5313-5327 Colorectal Cancer Surveillance: 2005 Update of an American Society of Clinical Oncology Practice Guideline Published in JCO, Vol. 23, Issue 33 (November 20), 2005: 8512-8519 American Society of Clinical Oncology Recommendations on Adjuvant Chemotherapy for Stage II Colon Cancer Published in JCO, Vol. 22, Issue 16 (August 15), 2004: 3408-3419 2000 Update of American Society of Clinical Oncology Colorectal Cancer Surveillance Guidelines Published in JCO, Vol. 18, Issue 20 (October 15), 2000: 3586-3588 Recommended Colorectal Cancer Surveillance Guidelines by the American Society of Clinical Oncology Published in JCO, Vol. 17, Issue 4 (April), 1999: 1312-1321 1997 Update of Recommendations for the Use of Tumor Markers in Breast and Colorectal Cancer Published in JCO, Vol. 16, Issue 2 (February), 1998: 793-795 Clinical Practice Guidelines for the Use of Tumor Markers in Breast and Colorectal Cancer Published in JCO, Vol. 14, Issue 10 (October), 1996: 2843-2877 [top] Genitourinary Cancer: Use of 5-α-Reductase Inhibitors for Prostate Cancer Chemoprevention: American Society of Clinical Oncology/American Urological Association 2008 Clinical Practice Guideline Published in JCO, Vol 27, Issue 9 (March 20), 2009: 1502-1516 American Society of Clinical Oncology Endorsement of the Cancer Care Ontario Practice Guideline on Nonhormonal Therapy for Men With Metastatic Hormone-Refractory (castration-resistant) Prostate Cancer Published in JCO, Vol 25, Issue 33 (November 20), 2007: 5313-5318 Initial Hormonal Management of Androgen-Sensitive Metastatic, Recurrent, or Progressive Prostate Cancer: 2006 Update of an American Society of Clinical Oncology Practice Guideline Published in JCO, Vol. 25, Issue 12 (April 20), 2007: 1596–1605 American Society of Clinical Oncology Recommendations for the Initial Hormonal Management of Androgen-Sensitive Metastatic, Recurrent, or Progressive Prostate Cancer Published in JCO, Vol. 22, Issue 14 (July 15), 2004: 2927-2941 [top] Head and Neck Cancer: American Society of Clinical Oncology Clinical Practice Guideline for the Use of Larynx-Preservation Strategies in the Treatment of Laryngeal Cancer Published in JCO, Vol. 24, Issue 22 (August 1), 2006: 3693–3704 [top] Hematologic Malignancies: American Society of Clinical Oncology 2007 Clinical Practice Guideline Update on the Role of Bisphosphonates in Multiple Myeloma Published in JCO, Vol. 25, Issue 17 (June 10), 2007: 2464–2472 American Society of Clinical Oncology Clinical Practice Guidelines: The Role of Bisphosphonates in Multiple Myeloma Published in JCO, Vol. 20, Issue 17 (September 1), 2002: 3719-3736 [top] Thoracic Cancer: Cancer Care Ontario and American Society of Clinical Oncology Adjuvant Chemotherapy and Adjuvant Radiation Therapy for Stages I-IIIA Resectable Non-Small-Cell Lung Cancer Guideline Published in JCO, Vol 25, Issue 34 (December 1), 2007: 5506-5518 American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003 Published in JCO, Vol. 22, Issue 2 (January 15), 2004: 330-353 American Society of Clinical Oncology Policy Statement Update: Tobacco Control - Reducing Cancer Incidence and Saving Lives Published in JCO, Vol. 21, Issue 14 (July 15), 2003: 2777-2786 Clinical Practice Guidelines for the Treatment of Unresectable Non-Small-Cell Lung Cancer Published in JCO, Vol. 15, Issue 8 (August), 1997: 2996-3018 [top] Supportive Care and Quality of Life: American Society of Clinical Oncology 2008 Clinical Practice Guideline Update: Use of Chemotherapy and Radiation Therapy Protectants Published in JCO, Vol 27, Issue 1 (January 1), 2009: 127-145 Use of Epoetin and Darbepoetin in Patients With Cancer: 2007 American Society of Clinical Oncology/American Society of Hematology Clinical Practice Guideline Update Published in JCO, Vol 26, Issue 1 (January 1), 2008: 132-149 American Society of Clinical Oncology Guideline: Recommendations for Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer Published in JCO, Vol. 25, Issue 34 (December 1), 2007: 5490-5505 American Society of Clinical Oncology Clinical Evidence Review on the Ongoing Care of Adult Cancer Survivors: Cardiac and Pulmonary Late Effects Published in JCO, Vol. 25, Issue 25 (September 1), 2007: 3991–4008 American Society of Clinical Oncology Guideline for Antiemetics in Oncology: Update 2006 Published in JCO, Vol. 24, Issue 18 (June 20), 2006: 2932-2947 2006 Update of Recommendations for the Use of White Blood Cell Growth Factors: An Evidence-Based Clinical Practice Guideline Published in JCO, Vol. 24, Issue 19 (July 1), 2006: 3187-3205 American Society of Clinical Oncology Technology Assessment Working Group Update: Use of Aromatase Inhibitors in the Adjuvant Setting Published in JCO, Vol. 21, Issue 13 (July 1), 2003: 2597-2599 2002 Update of Recommendations for the Use of Chemotherapy and Radiotherapy Protectants: Clinical Practice Guidelines of the American Society of Clinical Oncology Published in JCO, Vol. 20, Issue 12 (June 15), 2002: 2895-2903 Platelet Transfusion for Patients With Cancer: Clinical Practice Guidelines of the American Society of Clinical Oncology Published in JCO, Vol. 19, Issue 5 (March 1), 2001: 1519-1538 Use of Epoetin in Patients with Cancer: Evidence-Based Clinical Practice Guidelines of the American Society of Clinical Oncology and the American Society of Hematology Published in JCO, Vol. 20, Issue 19 (October 1), 2002: 4083-4107 2000 Update of Recommendations for the Use of Hematopoietic Colony-Stimulating Factors: Evidence-Based, Clinical Practice Guidelines Published in JCO, Vol. 18, Issue 20 (October 15), 2000: 3558-3585 Use of Hematopoietic Colony-Stimulating Factors: Comparison of the 1994 and 1997 American Society of Clinical Oncology Surveys Regarding ASCO Clinical Practice Guidelines Published in JCO, Vol. 17, Issue 11 (November), 1999: 3676-3681 American Society of Clinical Oncology Clinical Practice Guidelines for the Use of Chemotherapy and Radiotherapy Protectants Published in JCO, Vol. 17, Issue 10 (October), 1999: 3333-3355 Recommendations for the Use of Antiemetics: Evidence-Based, Clinical Practice Guidelines Published in JCO, Vol. 17, Issue 9 (September), 1999: 2971-2994 Cancer Care During the Last Phase of Life Published in JCO, Vol. 16, Issue 5 (May), 1998: 1986-1996 Update of Recommendations for the Use of Hematopoietic Colony-Stimulating Factors: Evidence-Based Clinical Practice Guidelines Published in JCO, Vol. 14, Issue 6 (June), 1996: 1957-1960 Outcomes of Cancer Treatment for Technology Assessment and Cancer Treatment Guidelines Published in JCO, Vol. 14, Issue 2 (February), 1996: 671-679 American Society of Clinical Oncology Recommendations for the Use of Hematopoietic Colony-Stimulating Factors: Evidence-Based, Clinical Practice Guidelines Published in JCO, Vol. 12, Issue 11 (November), 1994: 2471-2508 [top] Survivorship: American Society of Clinical Oncology Recommendations on Fertility Preservation in Cancer Patients Published in JCO, Vol. 24, Issue 18 (June 20), 2006: 2917-2931 [top] ASCO Special Articles American Society of Clinical Oncology Clinical Practice Guidelines: Opportunities and Challenges Published in JCO, Vol 26, Issue 24 (Aug 20), 2008:4022-4026 American Society of Clinical Oncology/National Comprehensive Cancer Network Quality Measures Published in JCO, Vol 26, Issue 21 (Jul 20), 2008:3631-3637 American Society of Clinical Oncology Statement on Minimum Standards and Exemplary Attributes of Clinical Trial Sites Published in JCO, Vol 26, Issue 15 (May 20), 2008:2562–2567 Ethical, Scientific, and Regulatory Perspectives Regarding the Use of Placebos in Cancer Clinical Trials Published in JCO, Vol 26, Issue 8 (March 10), 2008:1371-1378 Clinical Cancer Advances 2007: Major Research Advances in Cancer Treatment, Prevention, and Screening—A Report From the American Society of Clinical Oncology Published in JCO, Vol 26, Issue 2 (January 10), 2008: 313-325 Interactions With the Investment Industry: Practical and Ethical Implications Published in JCO, Vol. 25, Issue 3 (January 20), 2007: 338-340 Clinical Cancer Advances 2006: Major Research Advances in Cancer Treatment, Prevention, and Screening—A Report From the American Society of Clinical Oncology Published in JCO, Vol. 25, Issue 1 (January 1), 2007: 146-162 ASCO Core Values Published in JCO, Vol. 24, Issue 36 (December 20), 2006: 5780-5782 ASCO-ESMO Consensus Statement on Quality Cancer Care Published in JCO, Vol. 24, Issue 21 (July 20), 2006: 3498-3499 Introduction: ASCO-ESMO Consensus Statement on Quality Cancer Care Published in JCO, Vol. 24, Issue 21 (July 20), 2006: 3497 Reimbursement for Cancer Treatment: Coverage of Off-Label Drug Indications Published in JCO, Vol. 24, Issue 19 (July 1), 2006: 3206-3208 American Society of Clinical Oncology: Revised Conflict of Interest Policy Published in JCO, Vol. 24, Issue 3 (January 20), 2006: 519-521 Revisions of and Clarifications to the ASCO Conflict of Interest Policy Published in JCO, Vol. 24, Issue 3 (January 20), 2006: 517-518 Clinical Cancer Advances 2005: Major Research Advances in Cancer Treatment, Prevention, and Screening—A Report From the American Society of Clinical Oncology Published in JCO, Vol. 24, Issue 1 (January 1), 2006: 190-205 ACCO: ASCO Core Curriculum Outline Published in JCO, Vol. 23, Issue 9 (March 20), 2005: 2049-2077 Criteria for Facilities and Personnel for the Administration of Parenteral Systemic Antineoplastic Therapy Published in JCO, Vol. 22, Issue 22 (November 15), 2004: 4613-4615 American Society of Clinical Oncology: Revised Conflict of Interest Policy Published in JCO, Vol. 21, Issue 12 (June 15), 2003: 2394-2396 American Society of Clinical Oncology: Background for Update of Conflict of Interest Policy Published in JCO, Vol. 21, Issue 12 (June 15), 2003: 2387-2393 American Society of Clinical Oncology Policy Statement: Oversight of Clinical Research Published in JCO, Vol. 21, Issue 12 (June 15), 2003: 2377-2386 American Society of Clinical Oncology Statement Regarding the Use of Outside Services to Prepare or Administer Chemotherapy Drugs Published in JCO, Vol. 21, Issue 9 (May 1), 2003: 1882-1883 Perspectives on the Value of American Society of Clinical Oncology Clinical Guidelines as Reported by Oncologists and Health Maintenance Organizations Published in JCO, Vol. 21, Issue 5 (March 1), 2003: 937-941 American Society of Clinical Oncology 2001 Presidential Initiative: Impact of Regulatory Burdens on Quality Cancer Care Published in JCO, Vol. 20, Issue 24 (December 15), 2002: 4722-4726 Attitudes and Practices Among Pediatric Oncologists Regarding End-of-Life Care: Results of the 1998 American Society of Clinical Oncology Survey Published in JCO, Vol. 19, Issue 1 (January 1), 2001: 205-212 American Society of Clinical Oncology Guideline on the Role of Bisphosphonates in Breast Cancer Published in JCO, Vol. 18, Issue 6 (March 15), 2000: 1378-1391 Training Resource Document for Curriculum Development in Medical Oncology Published in JCO, Vol. 16, Issue 1 (January), 1998: 372-379 Criteria for Facilities and Personnel for the Administration of Parenteral Systemic Antineoplastic Therapy Published in JCO, Vol. 15, Issue 11 (November), 1997: 3416-3417 Resource Document for Curriculum Development in Cancer Genetics Education Published in JCO, Vol. 15, Issue 5 (May), 1997: 2157-2169 Critical Role of Phase I Clinical Trials in Cancer Treatment Published in JCO, Vol. 15, Issue 2 (February), 1997: 853-859 Funding for Clinical (Patient-Oriented) Oncology Research: Current Status and Recommendations for Improvement Published in JCO, Vol. 14, Issue 2 (February), 1996: 666-670 [top]

Advertisement   Advertisement